Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-31.14	83.22	120.86
Graham Fair Price	165.62	55.72	20.98
PEG	-93.98	0.06	-0.97
Price/Book	5.70	4.89	4.62
Price/Cash Flow	1.38	139.55	137.65
Prices/Earnings	-83.69	33.67	206.47
Price/Sales	-5.27	13.19	13.93
Price/FCF	1.38	139.55	137.65
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	9.31	0.46	0.42
Operating Margin	59.45	0.14	0.09
ROA	580.85	0.02	< 0.005
ROE	< 0.005	0.04	548.08
ROIC	0.15	0.03	-82.30
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.06	< 0.005	-1405.59
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	8.58	0.86	-90.01
EPS QOQ	2.14	5.79	170.72
FCF QOQ	3.08	0.09	-97.14
Revenue QOQ	0.05	0.16	202.76
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	123.27	99.45	-19.32
Days Sales Outstanding (DSO)	52.14	49.98	-4.14
Inventory Turnover	0.73	0.90	23.95
Debt/Capitalization	0.43	0.40	-5.91
Quick Ratio	0.47	0.50	4.85
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	59.10	61.67	4.34
Cash	3.35	3.17	-5.27
Capex	-0.76	-0.27	64.12
Free Cash Flow	1.99	2.16	8.78
Revenue	19.62	22.85	16.42
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.05	0.99	-5.36
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.86	10.15	-39.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating